Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Experimental Neurology

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.expneurol.2012.04.007PMID 22542947PMCID PMC3409566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The immunology of stroke: from mechanisms to translation

  2011cited by this paper
• Synaptic and Extrasynaptic NMDA Receptors Differentially Modulate Neuronal Cyclooxygenase-2 Function, Lipid Peroxidation, and Neuroprotection

  2011cited by this paper
• Neuroprotectin D1 Induces Neuronal Survival and Downregulation of Amyloidogenic Processing in Alzheimer’s Disease Cellular Models

  2011cited by this paper
• Antiplatelet Agents for Stroke Prevention

  2011cited by this paper
• Novel proresolving aspirin-triggered DHA pathway.

  2011influential reference
• Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1

  2010cited by this paper
• Study of vascular microdensity in areas of cerebral ischemia on experimental model.

  2010influential reference
• Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132.

  2010cited by this paper
• Beyond Neuroprotection to Brain Repair: Exploring the Next Frontier in Clinical Neuroscience to Expand the Therapeutic Window for Stroke

  2010influential reference
• Imaging the penumbra - strategies to detect tissue at risk after ischemic stroke.

  2009cited by this paper
• Penumbral selection of patients for trials of acute stroke therapy.

  2009cited by this paper
• MRI Identification of White Matter Reorganization Enhanced by Erythropoietin Treatment in a Rat Model of Focal Ischemia

  2009cited by this paper
• New approaches to therapy with omega-3 fatty acids

  2008cited by this paper
• A new penumbra: transitioning from injury into repair after stroke

  2008cited by this paper
• Stroke.

  2008cited by this paper
• Signal transduction in the retina

  2007cited by this paper
• Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection

  2007cited by this paper
• Resolvin E1 and protectin D1 activate inflammation-resolution programmes

  2007cited by this paper
• Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes.

  2006cited by this paper
• Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes1

  2006cited by this paper
• Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice.

  2006cited by this paper
• Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors.

  2006influential reference
• Astrocytes in cerebral ischemic injury: Morphological and general considerations

  2005cited by this paper
• Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress.

  2004cited by this paper
• Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.

  2004cited by this paper
• Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression*

  2003influential reference
• Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex.

  2003cited by this paper
• Relative indices of water diffusion anisotropy are equivalent in live and formalin‐fixed mouse brains

  2003influential reference
• Resolvins

  2002influential reference
• Diffusion tensor imaging: Concepts and applications

  2001cited by this paper
• Spatial Requirements for 15-(R)-Hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic Acid Synthesis within the Cyclooxygenase Active Site of Murine COX-2

  2000cited by this paper
• Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors

  1997cited by this paper
• Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

  1996influential reference
• COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex.

  1996cited by this paper
• Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.

  1995cited by this paper

• Molecular Features, Effective Sources, and Physiological Effects of Omega-3 Unsaturated Fatty Acids on Cardiovascular, Neurological, and Muscular Health, and Clinical Relevance for Several Conditions: A Narrative Review.

  2025cites this paper
• Dual Effects of Aspirin on Spatial Learning and Memory of Male Rats Following Induction of Permanent Cerebral Ischemia

  2025cites this paper
• Are there Effective Vegan-Friendly Supplements for Optimizing Health and Sports Performance? a Narrative Review

  2025cites this paper
• Impacts of Oxylipins on ischemic stroke: from pathophysiology to clinical phenotypes

  2025influential citation
• Immunological response and tissue loss in a rodent model of chronic traumatic brain injury treated with resolvin

  2025cites this paper
• Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation.

  2024cites this paper
• Nutrition in patients with traumatic brain injury: Nutrition in patients with TBI

  2024cites this paper
• Common lipidomic signatures across distinct acute brain injuries in patient outcome prediction.

  2024cites this paper
• Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators

  2023cites this paper
• Scoping review of disease-modifying effect of drugs in experimental epilepsy

  2023cites this paper
• Measuring brain docosahexaenoic acid turnover as a marker of metabolic consumption.

  2023cites this paper
• Levels of Arachidonic Acid–Derived Oxylipins and Anandamide Are Elevated Among Military APOE ɛ4 Carriers With a History of Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder Symptoms

  2023cites this paper
• Optimization of Nutrition after Brain Injury: Mechanistic and Therapeutic Considerations

  2023cites this paper
• Novel Lipid Mediators as a Promising Therapeutic Strategy for Ischemic Stroke.

  2023cites this paper
• Anti-Inflammatory, Neurotrophic, and Cytotoxic Oxylipins Isolated from Chaenomeles sinensis Twigs

  2023cites this paper
• The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis

  2023cites this paper
• Pro-resolving lipid mediators in traumatic brain injury: emerging concepts and translational approach.

  2022cites this paper
• Emerging Roles for the Orphan GPCRs, GPR37 and GPR37 L1, in Stroke Pathophysiology

  2022cites this paper
• Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions

  2022cites this paper
• Synergistic Neuroprotection by a PAF Antagonist Plus a Docosanoid in Experimental Ischemic Stroke: Dose-Response and Therapeutic Window

  2022cites this paper
• Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease

  2022cites this paper
• A Newly Synthesized 17-epi-Neuroprotectin D1/17-epi-Protectin D1: Authentication and Functional Regulation of Inflammation-Resolution.

  2022cites this paper
• Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications

  2022cites this paper
• COVID-19 and cancer: start the resolution!

  2022cites this paper
• Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development

  2022cites this paper
• Sarcopenia and the inflammatory cytokines

  2021cites this paper
• Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil

  2021cites this paper
• Role of polyunsaturated fatty acids in ischemic stroke - A perspective of specialized pro-resolving mediators.

  2021cites this paper
• GPR37 modulates progenitor cell dynamics in a mouse model of ischemic stroke.

  2021cites this paper
• Association between GFAP-positive astrocytes with clinically important parameters including neurological deficits and/or infarct volume in stroke-induced animals.

  2021cites this paper
• Docosahexaenoic acid modulates oxidative stress and monoamines levels in brain of streptozotocin-induced diabetic rats

  2021cites this paper
• Multiprong control of glioblastoma multiforme invasiveness: blockade of pro-inflammatory signaling, anti-angiogenesis, and homeostasis restoration

  2021cites this paper
• Resolution of inflammation and repair after ischemic brain injury

  2020cites this paper
• Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine

  2020cites this paper
• The role of bioactive lipids in attenuating the neuroinflammatory cascade in traumatic brain injury

  2020cites this paper
• Blocking pro-inflammatory platelet-activating factor receptors and activating cell survival pathways: A novel therapeutic strategy in experimental ischemic stroke

  2020cites this paper
• The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders

  2020cites this paper
• Cerebro-Cardiovascular Diseases

  2020cites this paper
• n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging

  2020cites this paper
• Specialized pro-resolving mediator network: an update on production and actions.

  2020cites this paper
• Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases

  2019cites this paper
• Bioactive Lipids in Inflammation After Central Nervous System Injury.

  2019cites this paper
• Direct and indirect effects of lipids on microglia function.

  2019cites this paper
• Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice

  2019cites this paper
• JLX001 Ameliorates Ischemia/Reperfusion Injury by Reducing Neuronal Apoptosis Via Downregulating JNK Signaling Pathway.

  2019cites this paper
• N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation

  2019cites this paper
• Polyunsaturated Fatty Acid Metabolism in the Brain and Brain Cells

  2019cites this paper
• Resolution of neuroinflammation: mechanisms and potential therapeutic option

  2019cites this paper
• Brain oxylipin concentrations following hypercapnia/ischemia: effects of brain dissection and dissection time[S]

  2018cites this paper
• Role of metabolic programming in the modulation of microglia phagocytosis by lipids.

  2018cites this paper
• Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury

  2018cites this paper
• Brain docosahexaenoic acid uptake and metabolism.

  2018cites this paper
• Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection.

  2018cites this paper
• Pro-resolving Mediators

  2018cites this paper
• Anti-Inflammatory Effects of Omega-3 Fatty Acids in the Brain: Physiological Mechanisms and Relevance to Pharmacology

  2018influential citation
• Immunopharmacology and Inflammation

  2018cites this paper
• Docosanoids Promote Neurogenesis and Angiogenesis, Blood-Brain Barrier Integrity, Penumbra Protection, and Neurobehavioral Recovery After Experimental Ischemic Stroke

  2018cites this paper
• Increased brain docosahexaenoic acid has no effect on the resolution of neuroinflammation following intracerebroventricular lipopolysaccharide injection

  2018cites this paper
• Therapeutic Advances in Neurological Disorders

  2018cites this paper
• Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury

  2017cites this paper
• Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms

  2017cites this paper
• Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease.

  2017cites this paper
• Selective Reduction of Brain Docosahexaenoic Acid after Experimental Brain Injury and Mitigation of Neuroinflammatory Outcomes with Dietary DHA

  2017cites this paper
• Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases.

  2017cites this paper
• Study of the effects of docosahexaenoic acid (DHA) and a structured phospholipid containing DHA on physiological and pathological conditions of neurogenesis in vitro

  2017cites this paper
• Dietary fish oil, and to a lesser extent the fat-1 transgene, increases astrocyte activation in response to intracerebroventricular amyloid-β 1–40 in mice

  2017cites this paper
• N-3 Polyunsaturated Fatty Acids and Neuroinflammation in Alzheimer's Disease

  2017cites this paper
• Docosahexaenoic acid (DHA), a fundamental fatty acid for the brain: New dietary sources.

  2017cites this paper
• Study of the effects of docosahexaenoic acid ( DHA ) and a structured phospholipid containing DHA on physiological and pathological conditions of neurogenesis in vitro

  2017cites this paper
• Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer's disease.

  2017cites this paper
• Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.

  2016influential citation
• N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update.

  2016cites this paper
• Central Role of Maladapted Astrocytic Plasticity in Ischemic Brain Edema Formation

  2016cites this paper
• Fish and Fish Oil for the Aging Brain

  2016cites this paper
• The Benefits of Natural Products for Neurodegenerative Diseases

  2016cites this paper
• Role of Polyunsaturated Fatty Acids and Their Metabolites on Stem Cell Proliferation and Differentiation.

  2016cites this paper
• N-3 PUFAs and neuroinflammatory processes in cognitive disorders

  2016cites this paper
• The Effect of Omega-3 Polyunsaturated Fatty Acids on the Resolution of Inflammation in the Rodent Brain

  2016influential citation
• Dihydroxylated E,E,Z-docosatrienes. An overview of their synthesis and biological significance.

  2016cites this paper
• Emerging roles of pro-resolving lipid mediators in immunological and adaptive responses to exercise-induced muscle injury.

  2016cites this paper
• Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid.

  2016cites this paper
• Resolution of Inflammation in the Lesioned Central Nervous System

  2015cites this paper
• Role of the heme oxygenase-adiponectin-atrial natriuretic peptide axis in renal function.

  2015cites this paper
• Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.

  2015cites this paper
• Neuroinflammatory processes in cognitive disorders: Is there a role for flavonoids and n-3 polyunsaturated fatty acids in counteracting their detrimental effects?

  2015influential citation
• Mammalian lipoxygenases and their biological relevance.

  2015cites this paper
• The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.

  2015cites this paper
• Intravenous infusion of docosahexaenoic acid increases serum concentrations in a dose-dependent manner and increases seizure latency in the maximal PTZ model.

  2015cites this paper
• Formation and Beneficial Roles of Polyunsaturated Lipid Mediators: Lipoxins, Resolvins, Protectins, and Maresins

  2015cites this paper
• Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse.

  2015cites this paper
• Resolution of inflammation as a therapeutic target for Alzheimer's disease

  2015cites this paper
• A versatile and stereocontrolled total synthesis of dihydroxylated docosatrienes containing a conjugated E,E,Z-triene.

  2014cites this paper
• Neurorestorative Targets of Dietary Long-Chain Omega-3 Fatty Acids in Neurological Injury

  2014cites this paper
• Pro-resolving lipid mediators are leads for resolution physiology

  2014cites this paper
• Polyunsaturated fatty acids and their metabolites in brain function and disease

  2014cites this paper
• Intraperitoneal administration of docosahexaenoic acid for 14days increases serum unesterified DHA and seizure latency in the maximal pentylenetetrazol model.

  2014cites this paper
• Confusion between protectin D1 (PD1) and its isomer protectin DX (PDX). An overview on the dihydroxy-docosatrienes described to date.

  2014cites this paper
• Resolution of inflammation in Alzheimer’s disease

  2014cites this paper
• Immunoresolving Lipid Mediators and Resolution of Inflammation in Aging

  2014cites this paper
• n-3 Fatty Acid-Derived Lipid Mediators against Neurological Oxidative Stress and Neuroinflammation

  2014cites this paper